Article Figures & Data
Tables
Characteristics No. (%) Sex Male 78 (60%) Female 52 (40%) Age, y <18 27 (20.77%) 18–49 100 (76.92%) ≥50 3 (2.31%) Initial presentation Hemorrhage 79 (60.77%) Ischemia 11 (8.46%) Headache 13 (10%) Seizures 20 (15.38%) No symptoms 7 (5.38%) - Table 2:
Preprocedual angioarchitectural characteristics of 130 patients with sbAVM embolization
Angiographic Features No. (%) Location Eloquent cortex 44 (33.85%) Noneloquent cortex 62 (47.69%) Midline 12 (9.23%) Deep 12 (9.23%) Size ≤3 cm 32 (24.62%) 3–6 cm 80 (61.54%) ≥6 cm 18 (13.85%) No. of feeders 1 17 (13.08%) 2 28 (21.54%) ≥3 85 (65.38%) Arterial feeders classification Terminal 95 (73.08%) Perforating 35 (26.92%) No. of draining veins 1 55 (42.31%) 2 37 (28.46%) ≥3 38 (29.23%) Venous drainage classification Exclusive superficial 79 (60.77%) Exclusive deep 16 (12.31%) Combined 35 (26.92%) Venous morphology Venous reflux 35 (26.92%) Venous ectasia 29 (22.31%) Venous stenosis 46 (35.38%) Coexisting aneurysm Intranidal 30 (23.08%) Perinidal 7 (5.38%) Spetzler-Martin classification I–II 50 (38.46%) III 36 (27.69%) IV 30 (23.08%) V 14 (10.77%) Complications No. (%) TND Ischemic 9 (6.92%) Hemorrhagic 4 (3.08%) PND Ischemic 7 (5.38%) Hemorrhagic 2 (1.54%) Death Hemorrhagic 1 (0.77%) Note:—TND indicates transient neurologic deficit; PND, persistent neurologic deficit.
- Table 5:
Demographic, clinical, and angioarchitectural characteristics predictive for embolization complications by univariate analysis
Characteristics OR (95% CI) P Value Sex Male 0.84 (0.33–2.10) .75 Age, y <18 0.89 (0.31–2.41) .78 18–49 1.09 (0.37–2.76) .84 ≥50 1.16 (0.17–11.36) 1.01 Initial presentation Hemorrhage 1.15 (0.59–2.94) .49 Ischemia 0.65 (0.14–3.27) 1.00 Headache 1.86 (0.93–5.63) .57 Seizures 0.64 (0.37–2.00) .55 No symptoms 0.91 (0.17–4.39) .70 Location Eloquent cortex 2.57 (1.08–3.42) .02 Noneloquent cortex 0.38 (0.24–0.86) .02 Midline 0.55 (0.19–2.42) .79 Deep 1.41 (0.29–2.85) .51 Size ≤3 cm 1.06 (0.42–2.40) .79 3–6 cm 0.80 (0.33–1.29) .23 ≥6 cm 2.45 (0.57–5.32) .17 No. of feeders 1 0.39 (0.06–1.54) .38 2 1.75 (0.76–3.21) .26 ≥3 0.85 (0.47–3.84) .72 Classification of feeders Terminal 0.61 (0.35–1.97) .32 Perforating 1.64 (0.79–4.58) .25 No. of draining veins 1 0.73 (0.43–2.96) .98 2 1.57 (0.58–3.63) .34 ≥3 0.62 (0.34–1.89) .43 Drainage classification Exclusive superficial 1.04 (0.77–2.52) .90 Exclusive deep 4.56 (1.28–9.67) .00 Combined 0.24 (0.09–0.53) .03 Venous morphology Venous reflux 1.91 (0.51–2.98) .77 Venous ectasia 2.24 (1.32–9.88) .26 Venous stenosis 1.50 (0.26–2.34) .19 Coexisting aneurysm Intranidal 0.99 (0.23–3.81) .22 Perinidal 1.52 (3.72–8.50) .61 Spetzler-Martin classification I–II 2.32 (0.21–9.87) .48 III 0.58 (0.70–4.05) .54 IV 1.61 (1.22–4.53) 1.20 V 0.83 (0.06–10.29) 1.00 Embolization degree Complete 0.87 (0.27–3.02) .27 Subtotal 0.71 (0.40–1.60) .13 Partial 1.92 (1.21–4.07) .17 Venous occlusion 1.26 (0.94–2.83) .84 - Table 6:
Spetzler-Martin classification and mRS score before and after embolization in 130 patients with sbAVMs
Grade Preprocedural, No. (%) Postprocedural, No. (%) Spetzler-Martin classification I 16 (16.31%) 34 (33.33%)a II 34 (26.15%) 20 (19.61%) III 36 (27.69%) 28 (27.45%) IV 30 (23.08%) 16 (15.69%) V 14 (10.77%) 4 (3.92%) mRS 0 10 (7.69%) 29 (22.31%)a 1 79 (60.77%) 54 (41.54%)a 2 19 (14.62%) 20 (15.38%) 3 11 (8.46%) 11 (8.46%) 4 5 (3.85%) 12 (9.23%) 5 6 (4.62%) 3 (2.31%) 6 0 (0%) 1 (0.77%) Note:—χ2 test.
↵a P < .05, significant difference.
- Table 7:
Embolization complications by n-BCA and/or Onyx according to the literature (11 series)
Series [Reference] Patients Materials Complication, % PND, % Mortality, % Taylor et al [2] 201 n-BCA/Onyx 21 11 2 Van Rooij et al [4] 44 Onyx 13.8 4.6 2.3 Katsaridis et al [5] 101 Onyx 14.9 7.9 2.9 Ledezma et al [7] 168 n-BCA 16.1 6.5 1.2 Haw et al [8] 306 n-BCA 6.4 3.9 0 Panagiotopoulos et al [11] 82 Onyx 19.5 3.8 2.4 Jayaraman et al [19] 192 n-BCA/Onyx 15.7 1.6 0 Starke et al [20] 275 n-BCA 14 2.5 0 Hauck et al [21] 107 Onyx 17 12.2 0 Velat et al [22] 88 n-BCA/Onyx 13.6 4.5 2.2 Present study 130 Onyx 17.7 6.9 0.8 Note:—PND indicates persistent neurologic deficit.